MIPSS70+ v2.0 predicts long-term survival in myelofibrosis after allogeneic HCT with the Flu/Mel conditioning regimen

Although allogeneic hematopoietic cell transplantation (allo-HCT) is the only curative treatment for myelofibrosis (MF), data are limited on how molecular markers predict transplantation outcomes. We retrospectively evaluated transplantation outcomes of 110 consecutive MF patients who underwent allo...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Blood Adv
Main Authors: Ali, Haris, Aldoss, Ibrahim, Yang, Dongyun, Mokhtari, Sally, Khaled, Samer, Aribi, Ahmed, Afkhami, Michelle, Al Malki, Monzr M., Cao, Thai, Mei, Matthew, O’Donnell, Margaret, Salhotra, Amandeep, Pullarkat, Vinod, Yang, Lixin, Stein, Anthony S., Marcucci, Guido, Forman, Stephen J., Nakamura, Ryotaro, Pillai, Raju, Snyder, David
Formato: Artigo
Idioma:Inglês
Publicado: American Society of Hematology 2019
Assuntos:
Transplantation
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6325305/
https://ncbi.nlm.nih.gov/pubmed/30622146
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2018026658
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares